Research Article

Control over Drug Acquisition, Preparation, and Injection: Implications for HIV and HCV Risk among Young Female Injection Drug Users

Table 2

Characteristics and social context of injection events among young female IDUs who inject ketamine ( ).

First injection of any drugFirst ketamine injection
(%) (%)

Type of drug
 Heroin16 (53.3)0 (—)
 Ketamine0 (—)30 (100)
 Methamphetamine8 (26.7)0 (—)
 Cocaine4 (13.3)0 (—)
 Other*2 (6.6)0 (—)
Using group
 Median size (range)2.0 (1–5)2.0 (1–15)
 Injected alone2 (6.7)2 (6.7)
Injection was planned16 (53.3)7 (23.3)
( = 29)
Paid for drug6 (20.7)10 (33.3)
( = 29)
Syringe source
 Primary9 (30.0)15 (50.0)
 Secondary18 (60.0)14 (46.7)
 Unknown3 (10.0)1 (3.3)
Injection equipment status
 Previously used syringe1 (3.3)4 (13.3)
  Cleaned the syringe before use0 (—)3 (75.0)
 Used equipment19 (63.3)22 (73.3)
Who prepared the drug?**
 Self6 (20.0)11 (36.7)
 Other24 (80.0)21 (70.0)
  Friend/acquaint.14 (58.3)17 (81.0)
  Stranger0 (—)0 (—)
  Girlfriend/boyfriend11 (45.8)4 (19.0)
  Family member0 (—)0 (—)
Who injected you with the drug?**
 Self5 (16.7)24 (80.0)
 Other25 (83.3)6 (20.0)
  Friend/acquaint.13 (52.0)4 (66.7)
  Stranger0 (—)0 (—)
  Girlfriend/boyfriend12 (48.0)2 (33.3)
  Family member0 (—)0 (—)

Includes alcohol, speedball, Ritalin, morphine, and Dilaudid.
**Categories are not mutually exclusive.